BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,028 | -15.9% | 2,970 | -9.0% | 0.00% | – |
Q2 2023 | $10,738 | +124.2% | 3,264 | +116.7% | 0.00% | – |
Q1 2023 | $4,790 | -71.0% | 1,506 | -36.9% | 0.00% | – |
Q4 2022 | $16,512 | +65.1% | 2,386 | +58.4% | 0.00% | – |
Q3 2022 | $10,000 | +66.7% | 1,506 | 0.0% | 0.00% | – |
Q2 2022 | $6,000 | -50.0% | 1,506 | -37.1% | 0.00% | – |
Q1 2022 | $12,000 | 0.0% | 2,396 | +87.3% | 0.00% | – |
Q4 2021 | $12,000 | -40.0% | 1,279 | +17.2% | 0.00% | – |
Q3 2021 | $20,000 | -31.0% | 1,091 | +24.3% | 0.00% | – |
Q2 2021 | $29,000 | +45.0% | 878 | +26.7% | 0.00% | – |
Q1 2021 | $20,000 | -23.1% | 693 | +21.8% | 0.00% | – |
Q4 2020 | $26,000 | 0.0% | 569 | +17.3% | 0.00% | – |
Q3 2020 | $26,000 | +271.4% | 485 | +311.0% | 0.00% | – |
Q2 2020 | $7,000 | +40.0% | 118 | +19.2% | 0.00% | – |
Q1 2020 | $5,000 | -91.7% | 99 | -85.2% | 0.00% | – |
Q4 2019 | $60,000 | +15.4% | 668 | +17.2% | 0.00% | – |
Q3 2019 | $52,000 | -48.0% | 570 | -26.9% | 0.00% | – |
Q2 2019 | $100,000 | -19.4% | 780 | -0.8% | 0.00% | – |
Q1 2019 | $124,000 | +65.3% | 786 | +4.0% | 0.00% | – |
Q4 2018 | $75,000 | -50.7% | 756 | -27.7% | 0.00% | – |
Q3 2018 | $152,000 | -50.6% | 1,045 | -46.8% | 0.00% | – |
Q2 2018 | $308,000 | -92.1% | 1,963 | -91.4% | 0.00% | -100.0% |
Q1 2018 | $3,910,000 | -4.4% | 22,891 | -0.3% | 0.00% | 0.0% |
Q4 2017 | $4,089,000 | +1173.8% | 22,960 | +881.2% | 0.00% | – |
Q3 2017 | $321,000 | +202.8% | 2,340 | +131.7% | 0.00% | – |
Q2 2017 | $106,000 | +10.4% | 1,010 | -4.7% | 0.00% | – |
Q1 2017 | $96,000 | +45.5% | 1,060 | +1.0% | 0.00% | – |
Q4 2016 | $66,000 | -25.0% | 1,050 | -19.2% | 0.00% | – |
Q3 2016 | $88,000 | +79.6% | 1,300 | +13.0% | 0.00% | – |
Q2 2016 | $49,000 | 0.0% | 1,150 | 0.0% | 0.00% | – |
Q1 2016 | $49,000 | -23.4% | 1,150 | +15.0% | 0.00% | – |
Q4 2015 | $64,000 | -50.0% | 1,000 | -33.4% | 0.00% | – |
Q3 2015 | $128,000 | +19.6% | 1,502 | +136.5% | 0.00% | – |
Q2 2015 | $107,000 | -8.5% | 635 | -35.1% | 0.00% | – |
Q1 2015 | $117,000 | +7.3% | 978 | -17.0% | 0.00% | – |
Q4 2014 | $109,000 | +319.2% | 1,178 | +68.3% | 0.00% | – |
Q2 2014 | $26,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
Summit X, LLC | 103,424 | $651,000 | 0.19% |